{"coredata": {"prism:url": "https://api.elsevier.com/content/article/pii/S1278321817300537", "dc:identifier": "doi:10.1016/j.canrad.2016.09.021", "eid": "1-s2.0-S1278321817300537", "prism:doi": "10.1016/j.canrad.2016.09.021", "pii": "S1278-3218(17)30053-7", "dc:title": "Intelligence artificielle appliqu\u00e9e \u00e0 la radioth\u00e9rapie ", "prism:publicationName": "Cancer/Radioth\u00e9rapie", "prism:aggregationType": "Journal", "pubType": "\n               Revue g\u00e9n\u00e9rale\n            ", "prism:issn": "12783218", "prism:volume": "21", "prism:issueIdentifier": "3", "prism:startingPage": "239", "prism:endingPage": "243", "prism:pageRange": "239-243", "prism:number": "3", "dc:format": "application/json", "prism:coverDate": "2017-05-31", "prism:coverDisplayDate": "May 2017", "prism:copyright": "\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.", "prism:publisher": "Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS.", "dc:creator": [{"@_fa": "true", "$": "Bibault, J.-E."}, {"@_fa": "true", "$": "Burgun, A."}, {"@_fa": "true", "$": "Giraud, P."}], "dc:description": "\n               R\u00e9sum\u00e9\n               \n                  La r\u00e9alisation d\u2019essais comparatifs randomis\u00e9s en radioth\u00e9rapie peut \u00eatre difficile lorsque de nouvelles modalit\u00e9s de traitement \u00e9mergent. Ainsi, peu ou pas d\u2019\u00e9tudes de phase 3\u00a0ont prouv\u00e9 l\u2019int\u00e9r\u00eat de la radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 dans la majorit\u00e9 de ses indications actuelles. Un nouveau paradigme se d\u00e9veloppe, consistant \u00e0 exploiter de larges bases de donn\u00e9es afin de r\u00e9pondre \u00e0 certaines questions cliniques ou translationnelles. Au-del\u00e0 des bases nationales (la SEER [Surveillance, Epidemiology, and End Results] ou la NCDB [National Cancer Database]), pour lesquelles le niveau de d\u00e9tails est souvent jug\u00e9 insuffisant au regard l\u2019h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 des populations et des traitements \u00e9tudi\u00e9s, la g\u00e9n\u00e9ralisation des dossiers m\u00e9dicaux \u00e9lectroniques permet maintenant au contraire de dresser des profils ph\u00e9notypiques tr\u00e8s d\u00e9taill\u00e9s. En parall\u00e8le, les syst\u00e8mes de radioth\u00e9rapie enregistrent avec pr\u00e9cision les traitements planifi\u00e9s et r\u00e9alis\u00e9s. Les techniques d\u2019intelligence artificielle et d\u2019apprentissage automatis\u00e9 permettent d\u2019exploiter de fa\u00e7on incr\u00e9mentale ces bases de donn\u00e9es massives afin de d\u00e9gager des hypoth\u00e8ses permettant de mieux personnaliser nos traitements. Cette revue d\u00e9taille comment ces m\u00e9thodes ont d\u00e9j\u00e0 \u00e9t\u00e9 exploit\u00e9es dans la litt\u00e9rature.\n               \n            \n               Abstract\n               \n                  Performing randomised comparative clinical trials in radiation oncology remains a challenge when new treatment modalities become available. One of the most recent examples is the lack of phase III trials demonstrating the superiority of intensity-modulated radiation therapy in most of its current indications. A new paradigm is developing that consists in the mining of large databases to answer clinical or translational issues. Beyond national databases (such as SEER or NCDB), that often lack the necessary level of details on the population studied or the treatments performed, electronic health records can be used to create detailed phenotypic profiles of any patients. In parallel, the Record-and-Verify Systems used in radiation oncology precisely document the planned and performed treatments. Artificial Intelligence and machine learning algorithms can be used to incrementally analyse these data in order to generate hypothesis to better personalize treatments. This review discusses how these methods have already been used in previous studies.\n               \n            ", "openaccess": "0", "openaccessArticle": false, "openaccessType": null, "openArchiveArticle": false, "openaccessSponsorName": null, "openaccessSponsorType": null, "openaccessUserLicense": null, "dcterms:subject": [{"@_fa": "true", "$": "Radioth\u00e9rapie"}, {"@_fa": "true", "$": "Mod\u00e8le pr\u00e9dictif"}, {"@_fa": "true", "$": "Intelligence artificielle"}, {"@_fa": "true", "$": "Apprentissage automatis\u00e9"}, {"@_fa": "true", "$": "Radiation oncology"}, {"@_fa": "true", "$": "Predictive model"}, {"@_fa": "true", "$": "Artificial intelligence"}, {"@_fa": "true", "$": "Machine learning"}], "link": [{"@href": "https://api.elsevier.com/content/article/pii/S1278321817300537", "@rel": "self", "@_fa": "true"}, {"@href": "https://www.sciencedirect.com/science/article/pii/S1278321817300537", "@rel": "scidir", "@_fa": "true"}]}, "scopus-id": "85017508142", "scopus-eid": "2-s2.0-85017508142", "pubmed-id": "28433591", "link": {"@href": "https://api.elsevier.com/content/abstract/scopus_id/85017508142", "@rel": "abstract"}, "originalText": {"xocs:doc": {"xocs:meta": {"xocs:open-access": {"xocs:oa-article-status": {"@is-open-access": "0", "@is-open-archive": "0"}}, "xocs:available-online-date": {"@yyyymmdd": "20170420", "$": "2017-04-20"}}}}}